Ceftriaxone 1000 mg IM Administration Instructions
For intramuscular (IM) administration of Ceftriaxone 1000 mg, reconstitute with an appropriate diluent, inject deep into a large muscle, and administer the full dose at once.
Reconstitution Instructions
Reconstitute the 1 gram vial with one of the following diluent volumes 1:
- 3.6 mL of diluent to achieve a concentration of 250 mg/mL
- 2.1 mL of diluent to achieve a concentration of 350 mg/mL
Appropriate diluents include:
- 1% Lidocaine solution (without epinephrine)
- Sterile water for injection
- 0.9% sodium chloride
Do NOT use diluents containing calcium, such as Ringer's solution or Hartmann's solution, as precipitation may occur 1
Administration Technique
- After reconstitution, shake the vial thoroughly until the powder is completely dissolved
- Withdraw the entire contents of the vial into the syringe
- Inject deep into a large muscle mass, such as the gluteus maximus (upper outer quadrant of buttock) or the lateral aspect of the thigh
- Aspirate before injection to avoid inadvertent injection into a blood vessel 1
- Administer the full dose at once
Important Considerations
Pain management: IM injection of ceftriaxone can be painful. Using 1% lidocaine as the diluent may help reduce injection pain 2
Injection site: Divide large volumes between two injection sites to minimize discomfort
Storage: After reconstitution, the solution should be used promptly. If not used immediately, store at room temperature (20-25°C) and use within 24 hours 1
Contraindications:
Dosing frequency: For most indications in adults, a single daily dose of 1-2 grams is sufficient 1
Monitoring
- Observe the patient for any immediate hypersensitivity reactions
- Monitor the injection site for pain, inflammation, or abscess formation
- No routine therapeutic drug monitoring is required for ceftriaxone 2
Clinical Pearls
- Ceftriaxone has an exceptionally long half-life (5.8-8.7 hours) compared to other cephalosporins, allowing for once-daily dosing 3
- After IM injection, peak plasma concentrations (approximately 81 μg/mL for a 1g dose) are achieved within 2-3 hours 4
- Intramuscular administration provides similar pharmacokinetics to intravenous administration, with plasma concentrations becoming equivalent by 2.5 hours post-administration 4
- The bioavailability of IM ceftriaxone is nearly 100%, making it an excellent option for outpatient parenteral therapy 5